Delivery Order SPE2DB20D7059-SPE2DB25FQAQ8

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,154.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,170.09 firm fixed-price delivery order is for the supply of 4566322557 - Clindamycin (Pedi) 75 mg/5 ml 100 ml. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,246.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a medical product, with a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
This federal contract award, with identification number SPE2DB20D3101|SPE2DB25FQYW5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.72 firm fixed-price delivery order is for the supply of 4566915822 CLINDAMYCIN 900 MG/50 ML-NS 50ML, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,684.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565158696 - CLINDAMYCIN 60ML 1S, a pharmaceutical product. The contract has a completion date of July 17, 2024 and is a Firm Fixed Price Delivery Order. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4562692183 CLINDAMYCIN 900 MG/50 ML-D5W 50ML, with a ceiling value of $2,616.04 and a period of performance through November 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,277.84 firm fixed price contract is for the provision of 4564002289 CLINDAMYCIN 900 MG/50 ML-D5W 50ML, a specialty pharmaceutical product. The delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC)...
This federal contract award, with ID SPE2DB20D1102|SPE2DB25FC5VM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,105.78 firm fixed-price delivery order is for the supply of 4566748547 - Clindamycin 900 mg/50 ml-D5W 50 ml. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime...
This federal contract award, with a ceiling value of $1,161.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Clindamycin PH 1% Solution, a pharmaceutical product, and has an ultimate completion date of January 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.85 firm fixed price contract is for the delivery of 4564886324 - CLINDAMYCIN PH 1% SOLUTION 60ML to support military healthcare programs. The contract has an ultimate completion date of June 13, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQAQ8
    Delivery Order

This federal contract award, with the ID SPE2DB20D7059|SPE2DB25FQAQ8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567351695 ! CLINDAMYCIN (PEDI) 75 MG/5 ML 100ML, a pharmaceutical product, with a ceiling value of $1,510.08. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 3:21 AM